Preclinical Evaluation of 111In-Labeled PEGylated Maytansine Nimotuzumab Drug Conjugates in EGFR-Positive Cancer Models-Reference-Cited by-同舟云学术

Preclinical Evaluation of 111In-Labeled PEGylated Maytansine Nimotuzumab Drug Conjugates in EGFR-Positive Cancer Models

Published:2019-01-17 Issue:8 Volume:60 Page:1103-1110
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Hartimath Siddesh V.,Alizadeh Elahe,Solomon Viswas Raja,Chekol Rufael,Bernhard Wendy,Hill Wayne,Parada Angel Casaco,Barreto Kris,Geyer Clarence Ronald,Fonge Humphrey

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference39 articles.

1. The protein tyrosine kinase family of the human genome

2. Increased Epidermal Growth Factor Receptor Gene Copy Number Is Associated With Poor Prognosis in Head and Neck Squamous Cell Carcinomas

3. Immunohistochemical expression of epidermal growth factor receptor, E-cadherin, and matrix metalloproteinase-9 in ovarian epithelial cancer and relation to patient deaths;Alshenawy;Ann Diagn Pathol.,2010

4. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

5. Quantitative Measurement of Epidermal Growth Factor Receptor Is a Negative Predictive Factor for Tamoxifen Response in Hormone Receptor–Positive Premenopausal Breast Cancer

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors;Future Medicinal Chemistry;2024-08-29

2. Efficacy of [⁶⁷Cu]Cu-EB-TATE Theranostic Against Somatostatin Receptor Subtype-2–Positive Neuroendocrine Tumors;Journal of Nuclear Medicine;2024-03-14

3. Effectiveness of [67Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-02-20

4. Preliminary PET Imaging of Microtubule-Based PET Radioligand [¹¹C]MPC-6827 in a Nonhuman Primate Model of Alzheimer’s Disease;ACS Chemical Neuroscience;2023-09-19

5. Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics;British Journal of Cancer;2023-04-24